Iridex (IRIX) Long-Term Deferred Tax (2011 - 2022)
Iridex (IRIX) posted Long-Term Deferred Tax of $80000.0 for Q4 2022, up 220.0% on a QoQ basis from $25000.0 in Q1 2022, and up 220.0% year-over-year from $25000.0 in Q4 2021.
Powered by 
Analysis
Iridex (IRIX) Long-Term Deferred Tax (2011 - 2022) Analysis & Trends
Iridex has reported Long-Term Deferred Tax for 6 years, with the latest figure at $80000.0 in Q4 2022.
- On a quarterly basis, Long-Term Deferred Tax rose 220.0% year-over-year to $80000.0 in Q4 2022; TTM through Dec 2022 was $80000.0, a 220.0% increase from a year earlier, with the FY2022 full-year figure at $80000.0, up 220.0% from the prior year.
- Long-Term Deferred Tax was $80000.0 for Q4 2022 at Iridex, up from $25000.0 in the prior quarter.
- The five-year high for Long-Term Deferred Tax was $80000.0 in Q4 2022, with the low at $25000.0 in Q1 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn |
| 10 | Iridex | 11.85 Mn | 7.17 Mn | 4.30 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | 80,000.00 |
| Jan 1, 2022 | 25,000.00 |
| Oct 1, 2016 | 8.99 Mn |
| Jul 2, 2016 | 8.99 Mn |
| Apr 2, 2016 | 8.99 Mn |
| Jan 2, 2016 | 8.99 Mn |
| Oct 3, 2015 | 7.15 Mn |
| Jul 4, 2015 | 7.15 Mn |
| Apr 4, 2015 | 7.00 Mn |
| Jan 3, 2015 | 7.15 Mn |
| Dec 28, 2013 | 10.00 Mn |
| Dec 29, 2012 | 10.10 Mn |
| Dec 31, 2011 | 11.70 Mn |